WoS SCIE Q3Scopus Q2SCImago #10,718CAS 4区Hybrid

Cellular Reprogramming

Abbreviation (ISO):CELL. REPROGRAMMING

Country: United States•WoS SCIE Quartile: Q3•Scopus SJR: 0.553•SCImago Rank: #10,718•Identifier (ISSN):2152-4971(Print)/2152-4998(Online)•Articles / Year: 29•Estimated Publication Fee (APC): $2,834 USD

Clarivate IF (2026)Q3

2.7

↑ +1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17

H-Index (2021)

57 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

29articles/year

7.41% Gold OA•70% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts

Latest Max Score

Estimated (Dec 26)

Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 2.7)

HĐGSNN Score History

By article publication year

Year	Max Score	Evaluation Details	Source
2026	1.75đ	WoS Q2 có IF ≥ 2.0(IF: 2.7)	🔵 Computed
2025	1.50đ	WoS Q2(IF: 1.7)	🔵 Computed
2024	1.50đ	WoS Q2(IF: 1.2)	🔵 Computed
2023	1.50đ	WoS Q2(IF: 1.6)	🔵 Computed
2022	1.75đ	WoS Q2 có IF ≥ 2.0(IF: 2.257)	🔵 Computed
2021	1.50đ	WoS Q2(IF: 1.987)	🔵 Computed
2020	1.50đ	WoS Q2(IF: 1.453)	🔵 Computed
2019	1.50đ	WoS Q2(IF: 1.43)	🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Cellular Reprogramming is the premier journal dedicated to providing new insights on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms. The Journal delivers information on cutting-edge techniques and the latest high-quality research and discoveries that are transforming biomedical research. Cellular Reprogramming coverage includes: Somatic cell nuclear transfer and reprogramming in early embryos Embryonic stem cells Nuclear transfer stem cells (stem cells derived from nuclear transfer embryos) Generation of induced pluripotent stem (iPS) cells and/or potential for cell-based therapies Epigenetics Adult stem cells and pluripotency.

Topics Covered (Recognized by AI)

BiologyGeneticsChemistryBiochemistryCell BiologyMedicineStem CellsMolecular BiologyFisheriesInternal MedicinePathologyImmunology

Primary Research Areas

Cell & Tissue Engineering Biotechnology & Applied Microbiology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,718Scopus Q2SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular Biology

Scopus Citation Rank (SJR)Q2

0.553

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2

Scopus H-Index (2025)

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)

Citations / Doc (2 years)

1.76

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,834 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations163

3-Year Documents101

Citable Documents87

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiotechnologyQ2

Developmental BiologyQ3

Cell BiologyQ4

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区CELL & TISSUE ENGINEERING

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed

Updating

Average time to first editorial decision

Online Publication Speed

Updating

Time from acceptance to online publication

Official Acceptance Rate

Updating

Manuscript acceptance rate confirmed by the publisher

Open Access Model

Hybrid

OA publishing option or traditional subscription

Publisher

Mary Ann Liebert Inc.

Publication Language

English

Frequency

Bimonthly

Founding Year

2010

Editorial Address

MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801

Indexing & Databases

SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

Category	Index	Rank	Quartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCRSCIE	112/180	Q3
CELL & TISSUE ENGINEERING	JCRSCIE	24/32	Q3
GENETICS & HEREDITY	JCRSCIE	92/192	Q2
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCISCIE	148/180	Q4
CELL & TISSUE ENGINEERING	JCISCIE	29/32	Q4
GENETICS & HEREDITY	JCISCIE	157/192	Q4